Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Vascular Pharmacology
  4. Fast Track Articles
  5. Fast Track Article
image of Emotional Stress in Cardiac and Vascular Diseases

Abstract

Introduction/Objective

Emotional, mental, or psychological distress, defined as increased symptoms of depression, anxiety, and/or stress, is common in patients with chronic diseases, such as cardiovascular (CV) disease (CVD).

Methods

Literature was reviewed regarding data from studies and meta-analyses examining the impact of emotional stress on the occurrence and outcome of several CVDs (coronary disease, heart failure, hypertension, arrhythmias, stroke). These influences' pathophysiology and clinical spectrum are detailed, tabulated, and pictorially illustrated.

Results

This type of stress is a newly recognized risk and prognosticator for CVD including coronary artery disease, heart failure, hypertension, cardiac arrhythmias, and stroke, independently of conventional risk factors. It can impact CV outcomes, and also affect health care utilization, with more patient visits to health care facilities. The biological systems activated by mental stress comprise the sympathetic nervous system (SNS), the renin-angiotensin system (RAS), and the hypothalamic-pituitary-adrenal (HPA) axis, while several other biological processes are disrupted, such as endothelial function, inflammatory responses, oxidative stress, mitochondrial function and the function of the amygdala which is the central nervous system processing center of emotions and emotional reactions.

Conclusion

Emotional stress that aggravates symptoms of depression, anxiety, and/or perceived mental stress is common in patients with chronic diseases, such as CVD. It is a newly recognized risk and prognosticator for several CVDs. It can influence CV outcomes, and also affect health care utilization. The biological systems activated by mental stress comprise the SNS, the RAS, and the HPA axis, while several other biological processes are disrupted.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cvp/10.2174/0115701611328094241104062903
2024-01-01
2025-01-18

  • From This Site

    /content/journals/cvp/10.2174/0115701611328094241104062903
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Kubzansky L.D. Huffman J.C. Boehm J.K. Hernandez R. Kim E.S. Koga H.K. Feig E.H. Lloyd-Jones D.M. Seligman M.E.P. Labarthe D.R. Positive Psychological Well-Being and Cardiovascular Disease. J. Am. Coll. Cardiol. 2018 72 12 1382 1396 10.1016/j.jacc.2018.07.042
    [Google Scholar]
  2. Bouchard V. Robitaille A. Perreault S. Cyr M.C. Tardif J.C. Busseuil D. D’Antono B. Psychological distress, social support, and use of outpatient care among adult men and women with coronary artery disease or other non-cardiovascular chronic disease. J. Psychosom. Res. 2023 165 111131 10.1016/j.jpsychores.2022.111131
    [Google Scholar]
  3. Vancheri F. Longo G. Vancheri E. Henein M.Y. Mental Stress and Cardiovascular Health—Part I. J. Clin. Med. 2022 11 12 3353 10.3390/jcm11123353
    [Google Scholar]
  4. Manolis A.A. Manolis T.A. Apostolopoulos E.J. Apostolaki N.E. Melita H. Manolis A.S. The role of the autonomic nervous system in cardiac arrhythmias: The neuro-cardiac axis, more foe than friend? Trends Cardiovasc. Med. 2021 31 5 290 302 10.1016/j.tcm.2020.04.011
    [Google Scholar]
  5. Chan B. Buckley T. Tofler G.H. Emotional Stress and Physical Exertion as Triggers of Acute Myocardial Infarction. Am. J. Cardiol. 2023 203 285 287 10.1016/j.amjcard.2023.07.085
    [Google Scholar]
  6. Manolis A.A. Manolis T.A. Melita H. Manolis A.S. Takotsubo Syndrome and Sudden Cardiac Death. Angiology 2023 74 2 105 128 10.1177/00033197221105757
    [Google Scholar]
  7. Manolis A.S. Manolis A.A. Manolis T.A. Melita H. Acute coronary syndromes in patients with angiographically normal or near normal (non-obstructive) coronary arteries. Trends Cardiovasc. Med. 2018 28 8 541 551 10.1016/j.tcm.2018.05.006
    [Google Scholar]
  8. Tsigos C. Kyrou I. Kassi E. Chrousos G.P. Stress: Endocrine Physiology and Pathophysiology. Endotext Anawalt B. Blackman M.R. Boyce A. Chrousos G. Corpas E. MDText.com, Inc. Feingold, KR 2000
    [Google Scholar]
  9. Yazgan I. Bartlett V. Romain G. Cleman J. Petersen-Crair P. Spertus J.A. Hardt M. Mena-Hurtado C. Smolderen K.G. Longitudinal Pathways Between Physical Activity, Depression, and Perceived Stress in Peripheral Artery Disease. Circ. Cardiovasc. Qual. Outcomes 2023 16 8 544 553 10.1161/CIRCOUTCOMES.122.009840
    [Google Scholar]
  10. Komasi S. Ahmadi M. Role of illness perception in explanation of severity of post-traumatic stress disorder symptoms after cardiovascular problems. ARYA Atheroscler. 2022 18 1 1 6
    [Google Scholar]
  11. Roy R. Mayer M.M. Dzekem B.S. Laiteerapong N. Screening for Emotional Distress in Patients with Cardiovascular Disease. Curr. Cardiol. Rep. 2023 25 10 1165 1174 10.1007/s11886‑023‑01936‑0
    [Google Scholar]
  12. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders (DSM–5). Available from: www.sciencetheearth.com/uploads/2/4/6/5/24658156/dsm-v-manual_pg490.pdf 2013
  13. Manolis T.A. Manolis A.A. Apostolopoulos E.J. Melita H. Manolis A.S. Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside. Curr. Vasc. Pharmacol. 2020 19 2 210 232 10.2174/1570161118666200325102411
    [Google Scholar]
  14. Jackson A.C. Grande M.R.L. Rogerson M.C. Ski C.F. Amerena J. Smith J.A. Hoover V. Alvarenga M.E. Higgins R.O. Thompson D.R. Murphy B.M. The cardiac distress inventory: A new measure of psychosocial distress associated with an acute cardiac event. BMC Cardiovasc. Disord. 2022 22 1 460 10.1186/s12872‑022‑02897‑y
    [Google Scholar]
  15. Le Grande M.R. Murphy B.M. Rogerson M.C. Ski C.F. Amerena J. Smith J.A. Hoover V. Alvarenga M.E. Higgins R.O. Thompson D.R. Jackson A.C. Development of a short form of the Cardiac Distress Inventory. BMC Cardiovasc. Disord. 2023 23 1 408 10.1186/s12872‑023‑03439‑w
    [Google Scholar]
  16. Kessler RC Green JG Gruber MJ Sampson NA Bromet E Cuitan M Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. Int J Methods Psychiatr Res 2010 19 Supp 1 4 22
    [Google Scholar]
  17. Dimsdale J.E. Psychological stress and cardiovascular disease. J. Am. Coll. Cardiol. 2008 51 13 1237 1246 10.1016/j.jacc.2007.12.024
    [Google Scholar]
  18. Osborne M.T. Shin L.M. Mehta N.N. Pitman R.K. Fayad Z.A. Tawakol A. Disentangling the Links Between Psychosocial Stress and Cardiovascular Disease. Circ. Cardiovasc. Imaging 2020 13 8 e010931 10.1161/CIRCIMAGING.120.010931
    [Google Scholar]
  19. O’ Riordan A. Howard S. Gallagher S. Blunted cardiovascular reactivity to psychological stress and prospective health: a systematic review. Health Psychol. Rev. 2023 17 1 121 147 10.1080/17437199.2022.2068639
    [Google Scholar]
  20. Chatkoff D.K. Maier K.J. Klein C. Nonlinear associations between chronic stress and cardiovascular reactivity and recovery. Int. J. Psychophysiol. 2010 77 2 150 156 10.1016/j.ijpsycho.2010.05.008
    [Google Scholar]
  21. Souama C. Lamers F. Milaneschi Y. Vinkers C.H. Defina S. Garvert L. Stein F. Woofenden T. Brosch K. Dannlowski U. Galenkamp H. de Graaf R. Jaddoe V.W.V. Lok A. van Rijn B.B. Völzke H. Cecil C.A.M. Felix J.F. Grabe H.J. Kircher T. Lekadir K. Have M. Walton E. Penninx B.W.J.H. Depression, cardiometabolic disease, and their co-occurrence after childhood maltreatment: an individual participant data meta-analysis including over 200,000 participants. BMC Med. 2023 21 1 93 10.1186/s12916‑023‑02769‑y
    [Google Scholar]
  22. Mrug S. Pollock J.S. Pollock D.M. Seifert M.E. Johnson K.A. Knight D.C. Early Life Stress, Coping, and Cardiovascular Reactivity to Acute Social Stress. Psychosom. Med. 2023 85 2 118 129
    [Google Scholar]
  23. Riahi S.M. Yousefi A. Saeedi F. Martin S.S. Associations of emotional social support, depressive symptoms, chronic stress, and anxiety with hard cardiovascular disease events in the United States: the multi-ethnic study of atherosclerosis (MESA). BMC Cardiovasc. Disord. 2023 23 1 236 10.1186/s12872‑023‑03195‑x
    [Google Scholar]
  24. Noble N.C. Merker J.B. Webber T.K. Ressler K.J. Seligowski A.V. PTSD and depression severity are associated with cardiovascular disease symptoms in trauma-exposed women. Eur. J. Psychotraumatol. 2023 14 2 2234810 10.1080/20008066.2023.2234810
    [Google Scholar]
  25. Gaffey A.E. Gathright E.C. Fletcher L.M. Goldstein C.M. Screening for Psychological Distress and Risk of Cardiovascular Disease and Related Mortality. J. Cardiopulm. Rehabil. Prev. 2022 42 6 404 415 10.1097/HCR.0000000000000751
    [Google Scholar]
  26. Kwapong Y.A. Boakye E. Khan S.S. Honigberg M.C. Martin S.S. Oyeka C.P. Hays A.G. Natarajan P. Mamas M.A. Blumenthal R.S. Blaha M.J. Sharma G. Association of Depression and Poor Mental Health With Cardiovascular Disease and Suboptimal Cardiovascular Health Among Young Adults in the United States. J. Am. Heart Assoc. 2023 12 3 e028332 10.1161/JAHA.122.028332
    [Google Scholar]
  27. Zou H. Chair S.Y. Zhang C. Bao A. Depressive and anxiety symptoms and illness perception among patients with acute coronary syndrome. J. Adv. Nurs. 2023 79 7 2632 2642 10.1111/jan.15612
    [Google Scholar]
  28. Tusa N. Kautiainen H. Elfving P. Sinikallio S. Mäntyselkä P. Depressive symptoms decrease health-related quality of life of patients with coronary artery disease and diabetes: a 12-month follow up study in primary care. Scand. J. Prim. Health Care 2023 41 3 276 286 10.1080/02813432.2023.2233995
    [Google Scholar]
  29. Liu Z. Liu Z. Zhou H. Zhou Y. Xu X. Li Z. Guo F. Wang Y. Zhou Z. Zhou L. Wang Y. Zhou X. Xia H. Jiang H. Increased sympathetic outflow induced by emotional stress aggravates myocardial ischemia–reperfusion injury via activation of TLR7/MyD88/IRF5 signaling pathway. Inflamm. Res. 2023 72 5 901 913 10.1007/s00011‑023‑01708‑0
    [Google Scholar]
  30. Mehta P.K. Sharma A. Bremner J.D. Vaccarino V. Mental Stress-Induced Myocardial Ischemia. Curr. Cardiol. Rep. 2022 24 12 2109 2120 10.1007/s11886‑022‑01821‑2
    [Google Scholar]
  31. Liljeroos T. Humphries S. Puthoopparambil S.J. Norlund F. Olsson E.M.G. Management of emotional distress following a myocardial infarction: a qualitative content analysis. Cogn. Behav. Ther. 2023 52 1 47 64 10.1080/16506073.2022.2135591
    [Google Scholar]
  32. Narendrula A. Ajani K. Lang J. Brinza E. Longenecker C.T. Psychological distress and health perception in patients with a previous myocardial infarction or stroke: a national cross-sectional study. BMC Cardiovasc. Disord. 2023 23 1 430 10.1186/s12872‑023‑03422‑5
    [Google Scholar]
  33. Gurgoglione F.L. Rizzello D. Giacalone R. Ferretti M. Vezzani A. Pfleiderer B. Pelà G. De Panfilis C. Cattabiani M.A. Benatti G. Tadonio I. Grassi F. Magnani G. Noni M. Cancellara M. Nicolini F. Ardissino D. Vignali L. Niccoli G. Solinas E. Precipitating factors in patients with spontaneous coronary artery dissection: Clinical, laboratoristic and prognostic implications. Int. J. Cardiol. 2023 385 1 7 10.1016/j.ijcard.2023.05.027
    [Google Scholar]
  34. Stanojevic D. Apostolovic S. Kostic T. Mitov V. Kutlesic-Kurtovic D. Kovacevic M. Stanojevic J. Milutinovic S. Beleslin B. A review of the risk and precipitating factors for spontaneous coronary artery dissection. Front. Cardiovasc. Med. 2023 10 1273301 10.3389/fcvm.2023.1273301
    [Google Scholar]
  35. Murphy B.M. Rogerson M.C. Hesselson S. Iismaa S.E. Hoover V. Le Grande M. Graham R.M. Jackson A.C. Prevalence of Anxiety, Depression, and Distress in SCAD and Non-SCAD AMI Patients. J. Cardiopulm. Rehabil. Prev. 2023 43 5 338 345 10.1097/HCR.0000000000000782
    [Google Scholar]
  36. Lee O. Sun K. Goldstein E. Jang J. Berenberg J. An Unusual Presentation of SCAD in a Young Male Soldier. Mil. Med. 2023
    [Google Scholar]
  37. Heikkilä K. Pentti J. Madsen I.E.H. Lallukka T. Virtanen M. Alfredsson L. Bjorner J. Borritz M. Brunner E. Burr H. Ferrie J.E. Knutsson A. Koskinen A. Leineweber C. Magnusson Hanson L.L. Nielsen M.L. Nyberg S.T. Oksanen T. Pejtersen J.H. Pietiläinen O. Rahkonen O. Rugulies R. Singh-Manoux A. Steptoe A. Suominen S. Theorell T. Vahtera J. Väänänen A. Westerlund H. Kivimäki M. Job Strain as a Risk Factor for Peripheral Artery Disease: A Multi‐Cohort Study. J. Am. Heart Assoc. 2020 9 9 e013538 10.1161/JAHA.119.013538
    [Google Scholar]
  38. Malik A.O. Peri-Okonny P. Gosch K. Thomas M. Mena C. Hiatt W.R. Jones P.G. Provance J.B. Labrosciano C. Jelani Q. Spertus J.A. Smolderen K.G. Association of Perceived Stress Levels With Long-term Mortality in Patients With Peripheral Artery Disease. JAMA Netw. Open 2020 3 6 e208741 10.1001/jamanetworkopen.2020.8741
    [Google Scholar]
  39. Smolderen K.G. Samaan Z. Decker C. Collins T. Lazar R.M. Itoga N.K. Mena-Hurtado C. Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circulation 2023 148 19 1511 1528 10.1161/CIR.0000000000001178
    [Google Scholar]
  40. Manolis A.S. Rhythm or Rate Control Management of Atrial Fibrillation: An Overrated Dilemma. Hellenic J. Cardiol. 2015 56 6 495 500
    [Google Scholar]
  41. Leo D.G. Ozdemir H. Lane D.A. Lip G.Y.H. Keller S.S. Proietti R. At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation. Front. Cardiovasc. Med. 2023 10 1171647 10.3389/fcvm.2023.1171647
    [Google Scholar]
  42. Zhao S.X. Tindle H.A. Larson J.C. Woods N.F. Crawford M.H. Hoover V. Salmoirago-Blotcher E. Shadyab A.H. Stefanick M.L. Perez M.V. Association Between Insomnia, Stress Events, and Other Psychosocial Factors and Incident Atrial Fibrillation in Postmenopausal Women: Insights From the Women’s Health Initiative. J. Am. Heart Assoc. 2023 12 17 e030030 10.1161/JAHA.123.030030
    [Google Scholar]
  43. Kim Y.G. Lee K.N. Han K.D. Han K.M. Min K. Choi H.Y. Choi Y.Y. Shim J. Choi J-I. Kim Y-H. Association of Depression With Atrial Fibrillation in South Korean Adults. JAMA Netw. Open 2022 5 1 e2141772 10.1001/jamanetworkopen.2021.41772
    [Google Scholar]
  44. Manolis T.A. Manolis A.A. Apostolopoulos E.J. Melita H. Manolis A.S. Depression and atrial fibrillation in a reciprocal liaison: a neuro-cardiac link. Int. J. Psychiatry Clin. Pract. 2023 27 4 397 415 10.1080/13651501.2023.2248214
    [Google Scholar]
  45. Manolis A.S. Estes N.A.M. III Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome. Am. J. Cardiol. 1989 64 3 194 198 10.1016/0002‑9149(89)90456‑6
    [Google Scholar]
  46. Manolis A.S. Katsaros C. Cokkinos D.V. Electrophysiological and electropharmacological studies in pre-excitation syndromes: results with propafenone therapy and isoproterenol infusion testing. Eur. Heart J. 1992 13 11 1489 1495 10.1093/oxfordjournals.eurheartj.a060091
    [Google Scholar]
  47. Manolis T.A. Manolis A.A. Manolis A.S. Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology 2019 70 2 103 129 10.1177/0003319718780145
    [Google Scholar]
  48. Schwartz P.J. Zaza A. Locati E. Moss A.J. Stress and sudden death. The case of the long QT syndrome. Circulation 1991 83 4 Suppl. Ii71 Ii80
    [Google Scholar]
  49. Pérez-Riera A.R. Barbosa-Barros R. de Rezende Barbosa M.P.C. Daminello-Raimundo R. de Lucca A.A. Jr de Abreu L.C. Catecholaminergic polymorphic ventricular tachycardia, an update. Ann. Noninvasive Electrocardiol. 2018 23 4 e12512 10.1111/anec.12512
    [Google Scholar]
  50. Kim C.W. Aronow W.S. Dutta T. Frenkel D. Frishman W.H. Catecholaminergic Polymorphic Ventricular Tachycardia. Cardiol. Rev. 2020 28 6 325 331 10.1097/CRD.0000000000000302
    [Google Scholar]
  51. Lip G.Y.H. Coca A. Kahan T. Boriani G. Manolis A.S. Olsen M.H. Oto A. Potpara T.S. Steffel J. Marín F. de Oliveira Figueiredo M.J. de Simone G. Tzou W.S. Chiang C-E. Williams B. Dan G-A. Gorenek B. Fauchier L. Savelieva I. Hatala R. van Gelder I. Brguljan-Hitij J. Erdine S. Lovič D. Kim Y-H. Salinas-Arce J. Field M. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace 2017 19 6 891 911 10.1093/europace/eux091
    [Google Scholar]
  52. Chung J. Robinson C. Sheffield L. Paramanathan P. Yu A. Ewusie J. Sanger S. Mitsnefes M. Parekh R.S. Sinha M.D. Rodrigues M. Thabane L. Dionne J. Chanchlani R. Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Hypertension 2023 80 11 2280 2292 10.1161/HYPERTENSIONAHA.123.20967
    [Google Scholar]
  53. Kjeldsen S.E. Hypertension and cardiovascular risk: General aspects. Pharmacol. Res. 2018 129 95 99 10.1016/j.phrs.2017.11.003
    [Google Scholar]
  54. Oshchepkov D.Y. Makovka Y.V. Ponomarenko M.P. Redina O.E. Markel A.L. Age-Dependent Changes in the Relationships between Traits Associated with the Pathogenesis of Stress-Sensitive Hypertension in ISIAH Rats. Int. J. Mol. Sci. 2023 24 13 10984 10.3390/ijms241310984
    [Google Scholar]
  55. Tomitani N. Kanegae H. Kario K. The effect of psychological stress and physical activity on ambulatory blood pressure variability detected by a multisensor ambulatory blood pressure monitoring device. Hypertens. Res. 2023 46 4 916 921 10.1038/s41440‑022‑01123‑8
    [Google Scholar]
  56. Fontes M.A.P. Marins F.R. Patel T.A. de Paula C.A. dos Santos Machado L.R. de Sousa Lima É.B. Ventris-Godoy A.C. Viana A.C.R. Linhares I.C.S. Xavier C.H. Filosa J.A. Patel K.P. Neurogenic Background for Emotional Stress-Associated Hypertension. Curr. Hypertens. Rep. 2023 25 7 107 116 10.1007/s11906‑023‑01235‑7
    [Google Scholar]
  57. Gong H.B. Wang L. Lv Q. Wang J. Improved systolic function of rat cardiocytes during heart failure by overexpression of SERCA2a. Eur. Rev. Med. Pharmacol. Sci. 2016 20 8 1590 1596
    [Google Scholar]
  58. Di Giacomo D. Ranieri J. Guerra F. Cilli E. Sciarra L. Romano S. Cardiovascular risk and biopsychosocial interplay: Association among hypertension, anxiety, and emotional dysregulation-observational study in primary care setting for efficient self-care. Clin. Cardiol. 2023
    [Google Scholar]
  59. Hirooka Y. Sympathetic Activation in Hypertension: Importance of the Central Nervous System. Am. J. Hypertens. 2020 33 10 914 926 10.1093/ajh/hpaa074
    [Google Scholar]
  60. Henein M.Y. Vancheri S. Longo G. Vancheri F. The Impact of Mental Stress on Cardiovascular Health—Part II. J. Clin. Med. 2022 11 15 4405 10.3390/jcm11154405
    [Google Scholar]
  61. Meredith I.T. Friberg P. Jennings G.L. Dewar E.M. Fazio V.A. Lambert G.W. Esler M.D. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 1991 18 5 575 582 10.1161/01.HYP.18.5.575
    [Google Scholar]
  62. Ferrier C. Cox H. Esler M. Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin. Sci. (Lond.) 1993 84 2 225 230 10.1042/cs0840225
    [Google Scholar]
  63. Walther L.M. Wirtz P.H. Physiological reactivity to acute mental stress in essential hypertension—a systematic review. Front. Cardiovasc. Med. 2023 10 1215710 10.3389/fcvm.2023.1215710
    [Google Scholar]
  64. Mancia G. Bertinieri G. Grassi G. Parati G. Pomidossi G. Ferrari A. Effects of blood-pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 1983 322 8352 695 698 10.1016/S0140‑6736(83)92244‑4
    [Google Scholar]
  65. Mancia G. Parati G. Pomidossi G. Grassi G. Casadei R. Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987 9 2 209 215 10.1161/01.HYP.9.2.209
    [Google Scholar]
  66. Julius S. Johnson E.H. Stress, autonomic hyperactivity and essential hypertension: an enigma. J. Hypertens. Suppl. 1985 3 4 S11 S17
    [Google Scholar]
  67. Esler M. Eikelis N. Schlaich M. Lambert G. Alvarenga M. Dawood T. Kaye D. Barton D. Pier C. Guo L. Brenchley C. Jennings G. Lambert E. Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin. Exp. Pharmacol. Physiol. 2008 35 4 498 502 10.1111/j.1440‑1681.2008.04904.x
    [Google Scholar]
  68. Mitchell D.A. Lambert G. Secher N.H. Raven P.B. Van Lieshout J. Esler M.D. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans. J. Physiol. 2009 587 11 2589 2597 10.1113/jphysiol.2008.167999
    [Google Scholar]
  69. Lambert G.W. Kaye D.M. Thompson J.M. Turner A.G. Cox H.S. Vaz M. Jennings Wallin Esler Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta Physiol. Scand. 1998 163 2 155 163 10.1046/j.1365‑201X.1998.00348.x
    [Google Scholar]
  70. Ferrier C. Jennings G.L. Eisenhofer G. Lambert G. Cox H.S. Kalff V. Kelly M. Esler M.D. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J. Hypertens. 1993 11 11 1217 1228 10.1097/00004872‑199311000‑00009
    [Google Scholar]
  71. Esler M. Julius S. Zweifler A. Randall O. Harburg E. Gardiner H. DeQuattro V. Mild high-renin essential hypertension. Neurogenic human hypertension? N. Engl. J. Med. 1977 296 8 405 411 10.1056/NEJM197702242960801
    [Google Scholar]
  72. Mancia G. Ferrari A. Gregorini L. Parati G. Pomidossi G. Bertinieri G. Grassi G. Zanchetti A. Blood pressure variability in man: its relation to high blood pressure, age and baroreflex sensitivity. Clin. Sci. 1980 59 s6 Suppl. 6 401s 404s 10.1042/cs059401s
    [Google Scholar]
  73. Mancia G. Ferrari A. Gregorini L. Parati G. Pomidossi G. Bertinieri G. Grassi G. di Rienzo M. Pedotti A. Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ. Res. 1983 53 1 96 104 10.1161/01.RES.53.1.96
    [Google Scholar]
  74. Mancia G. Parati G. Experience with 24-hour ambulatory blood pressure monitoring in hypertension. Am. Heart J. 1988 116 4 1134 1140 10.1016/0002‑8703(88)90177‑9
    [Google Scholar]
  75. Sega R. Facchetti R. Bombelli M. Cesana G. Corrao G. Grassi G. Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005 111 14 1777 1783 10.1161/01.CIR.0000160923.04524.5B
    [Google Scholar]
  76. Bombelli M. Toso E. Peronio M. Fodri D. Volpe M. Brambilla G. Facchetti R. Sega R. Grassi G. Mancia G. The Pamela study: main findings and perspectives. Curr. Hypertens. Rep. 2013 15 3 238 243 10.1007/s11906‑013‑0348‑1
    [Google Scholar]
  77. Mancia G. Parati G. Castiglioni P. di Rienzo M. Effect of sinoaortic denervation on frequency-domain estimates of baroreflex sensitivity in conscious cats. Am. J. Physiol. 1999 276 6 H1987 H1993
    [Google Scholar]
  78. Watson R.D.S. Stallard T.J. Littler W.A. Factors determining the variability of arterial pressure in hypertension. Clin. Sci. 1979 57 s5 Suppl. 5 283s 285s 10.1042/cs057283s
    [Google Scholar]
  79. Smith P.A. Graham L.N. Mackintosh A.F. Stoker J.B. Mary D.A.S.G. Sympathetic neural mechanisms in white-coat hypertension. J. Am. Coll. Cardiol. 2002 40 1 126 132 10.1016/S0735‑1097(02)01931‑9
    [Google Scholar]
  80. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am. J. Hypertens. 2010 23 10 1052 1060 10.1038/ajh.2010.154
    [Google Scholar]
  81. Cunningham S.C. Keleman A. Brandon R. Groninger H. BrintzenhofeSzoc K. Cardiac Related Psychosocial Distress and Traumatic Distress in Individuals with Advanced Heart Failure. J. Soc. Work End Life Palliat. Care 2023 19 2 103 117 10.1080/15524256.2023.2198158
    [Google Scholar]
  82. Anninos H. Manolis A.S. Takotsubo syndrome: A brief review in light of new evidence. Rhythmos 2016 11 4 90 95
    [Google Scholar]
  83. Basile C. Parlati A.L.M. Paolillo S. Marzano F. Nardi E. Chirico A. Depression in heart failure with reduced ejection fraction, an undervalued comorbidity: An up-to-date review. Medicina 2023 59 5
    [Google Scholar]
  84. Behnoush A.H. Khalaji A. Naderi N. Ashraf H. von Haehling S. ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison. ESC Heart Fail. 2023 10 3 1531 1544 10.1002/ehf2.14255
    [Google Scholar]
  85. Alnsasra H. Khalil F. Kanneganti Perue R. Azab A.N. Depression among Patients with an Implanted Left Ventricular Assist Device: Uncovering Pathophysiological Mechanisms and Implications for Patient Care. Int. J. Mol. Sci. 2023 24 14 11270 10.3390/ijms241411270
    [Google Scholar]
  86. Brouwers C. Denollet J. Caliskan K. de Jonge N. Constantinescu A. Young Q. Kaan A. Pedersen S.S. Psychological distress in patients with a left ventricular assist device and their partners: An exploratory study. Eur. J. Cardiovasc. Nurs. 2015 14 1 53 62 10.1177/1474515113517607
    [Google Scholar]
  87. Jalowiec A. Grady K.L. White-Williams C. Fazekas S. Laff M. Davidson-Bell V. Symptom distress three months after heart transplantation. J. Heart Lung Transplant. 1997 16 6 604 614
    [Google Scholar]
  88. Pätz T. Santoro F. Cetera R. Ragnatela I. El-Battrawy I. Mezger M. Rawish E. Andrés-Villarreal M. Almendro-Delia M. Martinez-Sellés M. Uribarri A. Pérez-Castellanos A. Guerra F. Novo G. Mariano E. Musumeci M.B. Arcari L. Cacciotti L. Montisci R. Akin I. Thiele H. Brunetti N.D. Vedia O. Núñez-Gil I.J. Eitel I. Stiermaier T. Trigger‐Associated Clinical Implications and Outcomes in Takotsubo Syndrome: Results From the Multicenter GEIST Registry. J. Am. Heart Assoc. 2023 12 14 e028511 10.1161/JAHA.122.028511
    [Google Scholar]
  89. Freiberger A. Richter C. Huber M. Beckmann J. Freilinger S. Kaemmerer H. Ewert P. Kohls N. Henningsen P. Allwang C. Andonian-Dierks C. Post-Traumatic Distress in Adults With Congenital Heart Disease: an Under-Recognized Complication? Am. J. Cardiol. 2023 203 9 16 10.1016/j.amjcard.2023.06.087
    [Google Scholar]
  90. Willinger L. Hock J. Hager A. Oberhoffer-Fritz R. Ewert P. Müller J. Heart-Focused Anxiety Is Prevalent in Adults With Congenital Heart Disease and Associated With Reduced Exercise Capacity. J. Cardiopulm. Rehabil. Prev. 2022 ••• 10.1097/HCR.0000000000000763
    [Google Scholar]
  91. Cassedy A. Wray J. Qadir A.A. Ernst M.M. Brown K. Franklin R. Wernovsky G. Marino B.S. Behavioral and Emotional Outcomes in Children with Congenital Heart Disease: Effects of Disease Severity, Family Life Stress, Disease-Related Chronic Stress, and Psychosocial Adaptation. J. Pediatr. 2023 259 113450 10.1016/j.jpeds.2023.113450
    [Google Scholar]
  92. Menillo A.M. Lee L.S. Pearson-Shaver A.L. Atrial Septal Defect. StatPearls Treasure Island (FL): StatPearls Publishing 2023
    [Google Scholar]
  93. Brida M. Chessa M. Celermajer D. Li W. Geva T. Khairy P. Griselli M. Baumgartner H. Gatzoulis M.A. Atrial septal defect in adulthood: a new paradigm for congenital heart disease. Eur. Heart J. 2022 43 28 2660 2671 10.1093/eurheartj/ehab646
    [Google Scholar]
  94. Cao W. Shen Y. Zhong J. Chen Z. Wang N. Yang J. The Patent Foramen Ovale and Migraine: Associated Mechanisms and Perspectives from MRI Evidence. Brain Sci. 2022 12 7 941 10.3390/brainsci12070941
    [Google Scholar]
  95. Manolis A.S. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature. Rev. Recent Clin. Trials 2017 12 2 129 138 10.2174/1574887112666170328124939
    [Google Scholar]
  96. Babateen O. Althobaiti F.S. Alhazmi M.A. Al-Ghamdi E. Alharbi F. Moffareh A.K. Matar F.M. Tawakul A. Samkari J.A. Association of Migraine Headache With Depression, Anxiety, and Stress in the Population of Makkah City, Saudi Arabia: A Cross-Sectional Study. Cureus 2023 15 5 e39788 10.7759/cureus.39788
    [Google Scholar]
  97. El-Sabawi B. Cloud H. Patel J.N. Bell S.P. Elmariah S. Fearon W.F. Kim J.B. Piana R.N. Kapadia S.R. Kumbhani D.J. Gillam L.D. Whisenant B.K. Quader N. Zajarias A. Welt F.G. Bavry A.A. Coylewright M. Vatterott A. Jackson N. Huang S. Lindman B.R. Association of Depression and Cognitive Dysfunction With Patient-Centered Outcomes After Transcatheter Aortic Valve Replacement. Circ. Cardiovasc. Interv. 2023 16 8 e012875 10.1161/CIRCINTERVENTIONS.123.012875
    [Google Scholar]
  98. Newell P. Zogg C. Shirley H. Feliz J. Hirji S. Harloff M. Kerolos M. Shah P. Kaneko T. The Effect of Psychosocial Risk Factors on Outcomes After Aortic Valve Replacement. JACC Cardiovasc. Interv. 2022 15 22 2326 2335 10.1016/j.jcin.2022.08.014
    [Google Scholar]
  99. Reddin C. Murphy R. Hankey G.J. Judge C. Xavier D. Rosengren A. Ferguson J. Alvarez-Iglesias A. Oveisgharan S. Iversen H.K. Lanas F. Al-Hussein F. Członkowska A. Oguz A. McDermott C. Pogosova N. Málaga G. Langhorne P. Wang X. Wasay M. Yusuf S. O’Donnell M. Rangaran S. Rao-Melacini P. Zhang X. Islam S. Kabali C. Cassanova A. Chin S.L. DeJesus J. Dehghan M. Agapay S. Diaz R. Varigos J. Avezum A. Liu L. Zhang H. Lopez-Jaramillo P. Rumboldt Z. Peñaherrera E. Diener H-C. Pais P. Albaker O. Yusoff K. Damasceno A. Ogah O. Iqbal R. Dans A. Ryglewicz D. De Villiers L. Elsayed A. Nilanont Y. Nidhinandana S. Mondo C. Yusufali A. Association of Psychosocial Stress With Risk of Acute Stroke. JAMA Netw. Open 2022 5 12 e2244836 10.1001/jamanetworkopen.2022.44836
    [Google Scholar]
  100. Kotlęga D. Gołąb-Janowska M. Masztalewicz M. Ciećwież S. Nowacki P. The emotional stress and risk of ischemic stroke. Neurol. Neurochir. Pol. 2016 50 4 265 270 10.1016/j.pjnns.2016.03.006
    [Google Scholar]
  101. Beech E.L. Riddell N. Murphy M.J. Crewther S.G. Sex and stress hormone dysregulation as clinical manifestations of hypothalamic function in migraine disorder: A meta‐analysis. Eur. J. Neurosci. 2023 58 4 3150 3171 10.1111/ejn.16087
    [Google Scholar]
  102. Valecha J. Khandait H. Sk A. Gupta V. Kumawat S. Anamika F.N.U. Jain R. Dua D. Migraine and heart: A reality check. Glob. Cardiol. Sci. Pract. 2023 2023 3 e202320 10.21542/gcsp.2023.20
    [Google Scholar]
  103. Chiang M.C. Dumitrascu O.M. Chhabra N. Chiang C.C. Migraine with Visual aura and the Risk of Stroke- a Narrative Review. J. Stroke Cerebrovasc. Dis. 2021 30 11 106067 10.1016/j.jstrokecerebrovasdis.2021.106067
    [Google Scholar]
  104. Manolis A.S. Manolis T.A. Manolis A.A. Melita H. Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down. Curr. Opin. Cardiol. 2021 36 2 241 251 10.1097/HCO.0000000000000838
    [Google Scholar]
  105. Manolis A.S. Manolis A.A. Manolis T.A. Apostolopoulos E.J. Papatheou D. Melita H. COVID-19 infection and cardiac arrhythmias. Trends Cardiovasc. Med. 2020 30 8 451 460 10.1016/j.tcm.2020.08.002
    [Google Scholar]
  106. Manolis A.S. Manolis A.A. Manolis T.A. Melita H. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges. J. Cardiovasc. Pharmacol. Ther. 2021 26 5 399 414 10.1177/10742484211011026
    [Google Scholar]
  107. Josephson R.A. Gillombardo C.B. Cardiovascular services in Covid-19 - Impact of the pandemic and lessons learned. Prog. Cardiovasc. Dis. 2023 76 12 19 10.1016/j.pcad.2023.01.005
    [Google Scholar]
  108. Franklin B.A. Rusia A. Haskin-Popp C. Tawney A. Chronic Stress, Exercise and Cardiovascular Disease: Placing the Benefits and Risks of Physical Activity into Perspective. Int. J. Environ. Res. Public Health 2021 18 18 9922 10.3390/ijerph18189922
    [Google Scholar]
  109. Manolis A.S. Manolis T.A. Manolis A.A. Papatheou D. Melita H. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management. J. Cardiovasc. Pharmacol. Ther. 2021 26 1 12 24 10.1177/1074248420958973
    [Google Scholar]
  110. Manolis A.S. Manolis T.A. Long COVID: An Emerging Puzzle. Rhythmos 2021 16 1 89 94
    [Google Scholar]
  111. von Känel R. Princip M. Holzgang S.A. Sivakumar S. Pazhenkottil A.P. Gomez Vieito D. Zuccarella-Hackl C. Sympathetic nervous system responses to acute psychosocial stress in male physicians with clinical burnout. Biol. Psychol. 2023 183 108687 10.1016/j.biopsycho.2023.108687
    [Google Scholar]
  112. Wekenborg M.K. Künzel R.G. Rothe N. Penz M. Walther A. Kirschbaum C. Thayer J.F. Hill L.B.K. Exhaustion and cardiovascular risk factors: the role of vagally-mediated heart rate variability. Ann. Epidemiol. 2023 87 93 99.e2 10.1016/j.annepidem.2023.09.008
    [Google Scholar]
  113. Caceres B.A. Britton L.E. Cortes Y.I. Makarem N. Suglia S.F. Investigating the associations between childhood trauma and cardiovascular health in midlife. J. Trauma. Stress 2022 35 2 409 423 10.1002/jts.22752
    [Google Scholar]
  114. Favre S. Bajwa N.M. Dominicé Dao M. Audétat Voirol M.C. Nendaz M. Junod Perron N. Perneger T. Richard-Lepouriel H. Association between burnout and stigma in physicians. PLoS One 2023 18 4 e0283556 10.1371/journal.pone.0283556
    [Google Scholar]
  115. Ghezzi E.S. Sharman R.L.S. Selvanayagam J.B. Psaltis P.J. Sanders P. Astley J.M. Knayfati S. Batra V. Keage H.A.D. Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients. Europace 2023 25 6 euad130 10.1093/europace/euad130
    [Google Scholar]
  116. F S.S. R H. A S. e J. S A. Z H. R N. Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD. Curr. Cardiol. Rep. 2023 25 9 1029 1039 10.1007/s11886‑023‑01924‑4
    [Google Scholar]
  117. van der Lingen A.L.C.J. Rijnierse M.T. Hooghiemstra A.M. Elshout S. van Halm V.P. Batelaan N.M. van Rossum A.C. Pedersen S.S. Leeuwis A.E. Allaart C.P. The link between cardiac status and depression and anxiety in implantable cardioverter defibrillator patients: Design and first results of the PSYCHE-ICD study. J. Psychosom. Res. 2023 167 111182 10.1016/j.jpsychores.2023.111182
    [Google Scholar]
  118. Metaxa S. Koulouris S. Manolis A.S. Electrical Storm: Clinical Management. Cardiac Arrhythmias Springer-Verlag: London 2014 293 304
    [Google Scholar]
  119. Lee K.S. Kim J.H. Kang K-W. Miller J. McEvedy S.M. Hwang S.Y. Moser D.K. Implantable Cardioverter Defibrillator Shocks and Psychological Distress. J. Cardiovasc. Nurs. 2020 35 1 66 73 10.1097/JCN.0000000000000610
    [Google Scholar]
  120. Vaccarino V. Bremner J.D. Stress and cardiovascular disease: an update. Nat. Rev. Cardiol. 2024 21 9 603 616 10.1038/s41569‑024‑01024‑y
    [Google Scholar]
  121. Wang L. de Kloet A.D. Pati D. Hiller H. Smith J.A. Pioquinto D.J. Ludin J.A. Oh S.P. Katovich M.J. Frazier C.J. Raizada M.K. Krause E.G. Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors. Neuropharmacology 2016 105 114 123 10.1016/j.neuropharm.2015.12.026
    [Google Scholar]
  122. Chrissobolis S. Luu A.N. Waldschmidt R.A. Yoakum M.E. D’Souza M.S. Targeting the renin angiotensin system for the treatment of anxiety and depression. Pharmacol. Biochem. Behav. 2020 199 173063 10.1016/j.pbb.2020.173063
    [Google Scholar]
  123. Skidgel R.A. Erdös E.G. The broad substrate specificity of human angiotensin I converting enzyme. Clin. Exp. Hypertens. A 1987 9 2-3 243 259 10.3109/10641968709164184
    [Google Scholar]
  124. Rimón R. Le Grevés P. Nyberg F. Heikkilä L. Salmela L. Terenius L. Elevation of substance P-like peptides in the CSF of psychiatric patients. Biol. Psychiatry 1984 19 4 509 516
    [Google Scholar]
  125. Kramer M.S. Cutler N. Feighner J. Shrivastava R. Carman J. Sramek J.J. Reines S.A. Liu G. Snavely D. Wyatt-Knowles E. Hale J.J. Mills S.G. MacCoss M. Swain C.J. Harrison T. Hill R.G. Hefti F. Scolnick E.M. Cascieri M.A. Chicchi G.G. Sadowski S. Williams A.R. Hewson L. Smith D. Carlson E.J. Hargreaves R.J. Rupniak N.M.J. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998 281 5383 1640 1645 10.1126/science.281.5383.1640
    [Google Scholar]
  126. Häfner S. Baumert J. Emeny R.T. Lacruz M.E. Bidlingmaier M. Reincke M. Ladwig K.H. Hypertension and depressed symptomatology: A cluster related to the activation of the renin–angiotensin–aldosterone system (RAAS). Findings from population based KORA F4 study. Psychoneuroendocrinology 2013 38 10 2065 2074 10.1016/j.psyneuen.2013.03.015
    [Google Scholar]
  127. Braszko J.J. Karwowska-Polecka W. Halicka D. Gard P.R. Captopril and enalapril improve cognition and depressed mood in hypertensive patients. J. Basic Clin. Physiol. Pharmacol. 2003 14 4 323 344 10.1515/JBCPP.2003.14.4.323
    [Google Scholar]
  128. Germain L. Chouinard G. Treatment of recurrent unipolar major depression with captopril. Biol. Psychiatry 1988 23 6 637 641 10.1016/0006‑3223(88)90010‑8
    [Google Scholar]
  129. Zubenko G.S. Nixon R.A. Mood-elevating effect of captopril in depressed patients. Am. J. Psychiatry 1984 141 1 110 111 10.1176/ajp.141.1.110
    [Google Scholar]
  130. Deicken R.F. Captopril treatment of depression. Biol. Psychiatry 1986 21 14 1425 1428 10.1016/0006‑3223(86)90334‑3
    [Google Scholar]
  131. Ferrario C.M. Chappell M.C. Tallant E.A. Brosnihan K.B. Diz D.I. Counterregulatory actions of angiotensin-(1-7). Hypertension 1997 30 3 535 541 10.1161/01.HYP.30.3.535
    [Google Scholar]
  132. Ohshima K. Mogi M. Nakaoka H. Iwanami J. Min L.J. Kanno H. Tsukuda K. Chisaka T. Bai H-Y. Wang X-L. Ogimoto A. Higaki J. Horiuchi M. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade. Hypertension 2014 63 3 e53 e59 10.1161/HYPERTENSIONAHA.113.02426
    [Google Scholar]
  133. Ancelin M-L. Carrière I. Scali J. Ritchie K. Chaudieu I. Ryan J. Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression. Transl. Psychiatry 2013 3 11 e322 10.1038/tp.2013.95
    [Google Scholar]
  134. Takami S. Imai Y. Katsuya T. Ohkubo T. Tsuji I. Nagai K. Satoh H. Hisamichi S. Higaki J. Ogihara T. Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction: The Ohasama study. Am. J. Hypertens. 2000 13 2 121 127 10.1016/S0895‑7061(99)00184‑3
    [Google Scholar]
  135. Henskens L.H.G. Kroon A.A. van Boxtel M.P.J. Hofman P.A.M. de Leeuw P.W. Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension. Stroke 2005 36 9 1869 1873 10.1161/01.STR.0000177867.39769.cb
    [Google Scholar]
  136. Taylor W.D. Benjamin S. McQuoid D.R. Payne M.E. Krishnan R.R. MacFall J.R. Ashley-Koch A. AGTR1 gene variation: Association with depression and frontotemporal morphology. Psychiatry Res. Neuroimaging 2012 202 2 104 109 10.1016/j.pscychresns.2012.03.007
    [Google Scholar]
  137. Baghai T.C. Schule C. Zill P. Deiml T. Eser D. Zwanzger P. Ella R. Rupprecht R. Bondy B. The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men. Neurosci. Lett. 2004 363 1 38 42 10.1016/j.neulet.2004.03.052
    [Google Scholar]
  138. Bahramali E. Firouzabadi N. Yavarian I. Shayesteh M.R.H. Erfani N. Shoushtari A.A. Asadpour R. Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. Eur. J. Clin. Pharmacol. 2016 72 9 1059 1064 10.1007/s00228‑016‑2079‑0
    [Google Scholar]
  139. Brownstein D.J. Salagre E. Köhler C. Stubbs B. Vian J. Pereira C. Chavarria V. Karmakar C. Turner A. Quevedo J. Carvalho A.F. Berk M. Fernandes B.S. Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. Aust. N. Z. J. Psychiatry 2018 52 1 24 38 10.1177/0004867417721654
    [Google Scholar]
  140. Khoury N.M. Marvar P.J. Gillespie C.F. Wingo A. Schwartz A. Bradley B. Kramer M. Ressler K.J. The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J. Clin. Psychiatry 2012 73 6 849 855 10.4088/JCP.11m07316
    [Google Scholar]
  141. Balthazar L. Lages Y.V.M. Romano V.C. Landeira-Fernandez J. Krahe T.E. The association between the renin-angiotensin system and the hypothalamic-pituitary-adrenal axis in anxiety disorders: A systematic review of animal studies. Psychoneuroendocrinology 2021 132 105354 10.1016/j.psyneuen.2021.105354
    [Google Scholar]
  142. Grippo A.J. Johnson A.K. Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009 12 1 1 21 10.1080/10253890802046281
    [Google Scholar]
  143. Carroll B.J. Curtis G.C. Neuroendocrine identification of depressed patients. Aust. N. Z. J. Psychiatry 1976 10 1 13 20 10.3109/00048677609159480
    [Google Scholar]
  144. Baghai T.C. Binder E.B. Schule C. Salyakina D. Eser D. Lucae S. Zwanzger P. Haberger C. Zill P. Ising M. Deiml T. Uhr M. Illig T. Wichmann H-E. Modell S. Nothdurfter C. Holsboer F. Müller-Myhsok B. Möller H-J. Rupprecht R. Bondy B. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol. Psychiatry 2006 11 11 1003 1015 10.1038/sj.mp.4001884
    [Google Scholar]
  145. Vaidya V.A. Stress, depression and hippocampal damage. J. Biosci. 2000 25 2 123 124
    [Google Scholar]
  146. Weber B. Lewicka S. Deuschle M. Colla M. Vecsei P. Heuser I. Increased diurnal plasma concentrations of cortisone in depressed patients. J. Clin. Endocrinol. Metab. 2000 85 3 1133 1136 10.1210/jcem.85.3.6469
    [Google Scholar]
  147. Asnis G.M. Halbreich U. Ryan N.D. Rabinowicz H. Puig-Antich J. Nelson B. Novacenko H. Friedman J.H. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology 1987 12 4 295 301 10.1016/0306‑4530(87)90054‑0
    [Google Scholar]
  148. Maes M. Lin A. Bonacccorso S. Van Hunsel F. Gastel A.V. Delmeire L. Biondi M. Bosmans E. Kenis G. Scharpé S. Increased 24‐hour urinary cortisol excretion in patients with post‐traumatic stress disorder and patients with major depression, but not h patients with fibromyalgia. Acta Psychiatr. Scand. 1998 98 4 328 335 10.1111/j.1600‑0447.1998.tb10092.x
    [Google Scholar]
  149. Leistner C. Menke A. Hypothalamic–pituitary–adrenal axis and stress. Handb. Clin. Neurol. 2020 175 55 64 10.1016/B978‑0‑444‑64123‑6.00004‑7
    [Google Scholar]
  150. Malekpour M. Shekouh D. Safavinia M.E. Shiralipour S. Jalouli M. Mortezanejad S. Azarpira N. Ebrahimi N.D. Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery. Front. Psychiatry 2023 14 1182345 10.3389/fpsyt.2023.1182345
    [Google Scholar]
  151. Menke A. The HPA Axis as Target for Depression. Curr. Neuropharmacol. 2023
    [Google Scholar]
  152. Henein M.Y. Vancheri S. Longo G. Vancheri F. The Role of Inflammation in Cardiovascular Disease. Int. J. Mol. Sci. 2022 23 21 12906 10.3390/ijms232112906
    [Google Scholar]
  153. Manolis A.S. Manolis T.A. Melita H. Atherosclerosis: an Athero-Thrombo-Inflammatory Disease. Hosp. Chron. 2012 7 4 195 201
    [Google Scholar]
  154. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr. Rev. 2007 65 12 140 146 10.1301/nr.2007.dec.S140‑S146
    [Google Scholar]
  155. Hou R. Ye G. Liu Y. Chen X. Pan M. Zhu F. Fu J. Fu T. Liu Q. Gao Z. Baldwin D.S. Tang Z. Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder. Brain Behav. Immun. 2019 81 105 110 10.1016/j.bbi.2019.06.001
    [Google Scholar]
  156. Sumner J.A. Cleveland S. Chen T. Gradus J.L. Psychological and biological mechanisms linking trauma with cardiovascular disease risk. Transl. Psychiatry 2023 13 1 25 10.1038/s41398‑023‑02330‑8
    [Google Scholar]
  157. Elgellaie A. Thomas S.J. Kaelle J. Bartschi J. Larkin T. Pro‐inflammatory cytokines IL‐1α, IL‐6 and TNF‐α in major depressive disorder: Sex‐specific associations with psychological symptoms. Eur. J. Neurosci. 2023 57 11 1913 1928 10.1111/ejn.15992
    [Google Scholar]
  158. Balasubramanian R. Shutta K.H. Guasch-Ferre M. Huang T. Jha S.C. Zhu Y. Shadyab A.H. Manson J.A.E. Corella D. Fitó M. Hu F.B. Rexrode K.M. Clish C.B. Hankinson S.E. Kubzansky L.D. Metabolomic profiles of chronic distress are associated with cardiovascular disease risk and inflammation-related risk factors. Brain Behav. Immun. 2023 114 262 274 10.1016/j.bbi.2023.08.010
    [Google Scholar]
  159. Dyball D. Bennett A.N. Schofield S. Cullinan P. Boos C.J. Bull A.M.J. Stevelink S.A.M. Fear N.T. The underlying mechanisms by which PTSD symptoms are associated with cardiovascular health in male UK military personnel: The ADVANCE cohort study. J. Psychiatr. Res. 2023 159 87 96 10.1016/j.jpsychires.2023.01.010
    [Google Scholar]
  160. Huang Q. Zhang H. Zhou R. Stress reappraisal improves the autonomic nervous system response of test anxious individuals: Evidence from heart rate variability. Neurosci. Lett. 2023 812 137372 10.1016/j.neulet.2023.137372
    [Google Scholar]
  161. Soufer R. Jain H. Yoon A.J. Heart-brain interactions in mental stress-induced myocardial ischemia. Curr. Cardiol. Rep. 2009 11 2 133 140 10.1007/s11886‑009‑0020‑1
    [Google Scholar]
  162. Delavari F. Rafi H. Sandini C. Murray R.J. Latrèche C. Van De Ville D. Eliez S. Amygdala subdivisions exhibit aberrant whole-brain functional connectivity in relation to stress intolerance and psychotic symptoms in 22q11.2DS. Transl. Psychiatry 2023 13 1 145 10.1038/s41398‑023‑02458‑7
    [Google Scholar]
  163. Ebong I.A. Quesada O. Fonkoue I.T. Mattina D. Sullivan S. Oliveira G.M.M. Spikes T. Sharma J. Commodore Y. Ogunniyi M.O. Aggarwal N.R. Vaccarino V. The Role of Psychosocial Stress on Cardiovascular Disease in Women. J. Am. Coll. Cardiol. 2024 84 3 298 314 10.1016/j.jacc.2024.05.016
    [Google Scholar]
  164. Hu J.R. Abdullah A. Nanna M.G. Soufer R. The Brain–Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease. Curr. Cardiol. Rep. 2023 25 12 1745 1758 10.1007/s11886‑023‑01990‑8
    [Google Scholar]
  165. Black P.H. Garbutt L.D. Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 2002 52 1 1 23 10.1016/S0022‑3999(01)00302‑6
    [Google Scholar]
  166. Marvar P.J. Andero R. Hurlemann R. Lago T.R. Zelikowsky M. Dabrowska J. Limbic Neuropeptidergic Modulators of Emotion and Their Therapeutic Potential for Anxiety and Post-Traumatic Stress Disorder. J. Neurosci. 2021 41 5 901 910 10.1523/JNEUROSCI.1647‑20.2020
    [Google Scholar]
  167. Korinek K. Young Y. Teerawichitchainan B. Kim Chuc N.T. Kovnick M. Zimmer Z. Is war hard on the heart? Gender, wartime stress and late life cardiovascular conditions in a population of Vietnamese older adults. Soc. Sci. Med. 2020 265 113380 10.1016/j.socscimed.2020.113380
    [Google Scholar]
  168. O’Donnell C.J. Schwartz Longacre L. Cohen B.E. Fayad Z.A. Gillespie C.F. Liberzon I. Pathak G.A. Polimanti R. Risbrough V. Ursano R.J. Vander Heide R.S. Yancy C.W. Vaccarino V. Sopko G. Stein M.B. Posttraumatic Stress Disorder and Cardiovascular Disease. JAMA Cardiol. 2021 6 10 1207 1216 10.1001/jamacardio.2021.2530
    [Google Scholar]
  169. Kreatsoulas C. Fleegler E.W. Kubzansky L.D. McGorrian C.M. Subramanian S.V. Young Adults and Adverse Childhood Events: A Potent Measure of Cardiovascular Risk. Am. J. Med. 2019 132 5 605 613 10.1016/j.amjmed.2018.12.022
    [Google Scholar]
  170. Chou P.H. Koenen K.C. Associations between childhood maltreatment and risk of myocardial infarction in adulthood: Results from the National Epidemiologic Survey on alcohol and Related Conditions. J. Psychiatr. Res. 2019 116 172 177 10.1016/j.jpsychires.2018.12.001
    [Google Scholar]
  171. Jakubowski K.P. Cundiff J.M. Matthews K.A. Cumulative childhood adversity and adult cardiometabolic disease: A meta-analysis. Health Psychol. 2018 37 8 701 715 10.1037/hea0000637
    [Google Scholar]
  172. Seligowski A.V. Grewal S.S. Abohashem S. Zureigat H. Qamar I. Aldosoky W. Gharios C. Hanlon E. Alani O. Bollepalli S.C. Armoundas A. Fayad Z.A. Shin L.M. Osborne M.T. Tawakol A. PTSD increases risk for major adverse cardiovascular events through neural and cardio-inflammatory pathways. Brain Behav. Immun. 2024 117 149 154 10.1016/j.bbi.2024.01.006
    [Google Scholar]
  173. Buto P.T. Shah A. Pearce B.D. Lima B.B. Almuwaqqat Z. Martini A. Al-Abboud O. Tarlapally N. Sullivan S. Sun Y.V. Murrah N.V. Driggers E. Shallenberger L. Lewis T.T. Elon L. Bremner J.D. Raggi P. Quyyumi A. Vaccarino V. Association of systemic inflammation with posttraumatic stress disorder after a myocardial infarction. Brain, Behavior, & Immunity - Health 2023 30 100629 10.1016/j.bbih.2023.100629
    [Google Scholar]
  174. Pivato C.A. Chandiramani R. Petrovic M. Nicolas J. Spirito A. Cao D. Mehran R. Depression and ischemic heart disease. Int. J. Cardiol. 2022 364 9 15 10.1016/j.ijcard.2022.05.056
    [Google Scholar]
  175. White K.S. Pardue C. Ludbrook P. Sodhi S. Esmaeeli A. Cedars A. Cardiac Denial and Psychological Predictors of Cardiac Care Adherence in Adults With Congenital Heart Disease. Behav. Modif. 2016 40 1-2 29 50 10.1177/0145445515613329
    [Google Scholar]
  176. Salas J. Scherrer J.F. Tuerk P. van den Berk-Clark C. Chard K.M. Schneider F.D. Schnurr P.P. Friedman M.J. Norman S.B. Cohen B.E. Lustman P. Large posttraumatic stress disorder improvement and antidepressant medication adherence. J. Affect. Disord. 2020 260 119 123 10.1016/j.jad.2019.08.095
    [Google Scholar]
  177. Halje K. Timpka T. Tylestedt P. Adler A.K. Fröberg L. Schyman T. Johansson K. Dahl K. Self-referral psychological treatment centre for young adults: a 2-year observational evaluation of routine practice before and after treatment. BMJ Open 2015 5 8 e008030 10.1136/bmjopen‑2015‑008030
    [Google Scholar]
  178. Ljubotina A. Mićović V. Kapović M. Ljubotina M. Popović B. Materljan E. Perception of stress, depression, hypertension and myocardial infarction as predictors of adherence to hypertension drug treatment. Coll. Antropol. 2014 38 4 1179 1186
    [Google Scholar]
  179. Rao A. Zecchin R. Newton P.J. Phillips J.L. DiGiacomo M. Denniss A.R. Hickman L.D. The prevalence and impact of depression and anxiety in cardiac rehabilitation: A longitudinal cohort study. Eur. J. Prev. Cardiol. 2020 27 5 478 489 10.1177/2047487319871716
    [Google Scholar]
  180. De Santis S. Ladisa V. Giovannico L. Fischetti G. Parigino D. Savino L. Silva A.M. Di Bari N. Taurisano P. De Caro M.F. Bottio T. Psychological assessment of patients on the heart transplant waiting list: A single center experience. Clin. Transplant. 2024 38 5 e15328 10.1111/ctr.15328
    [Google Scholar]
  181. Ski C.F. Taylor R.S. McGuigan K. Long L. Lambert J.D. Richards S.H. Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation. Cochrane Database Syst. Rev. 2024 4 4 Cd013508
    [Google Scholar]
  182. Perk J. De Backer G. Gohlke H. Graham I. Reiner Z. Verschuren M. Albus C. Benlian P. Boysen G. Cifkova R. Deaton C. Ebrahim S. Fisher M. Germano G. Hobbs R. Hoes A. Karadeniz S. Mezzani A. Prescott E. Ryden L. Scherer M. Syvanne M. Scholte Op Reimer W.J.M. Vrints C. Wood D. Zamorano J.L. Zannad F. Cooney M.T. Bax J. Baumgartner H. Ceconi C. Dean V. Deaton C. Fagard R. Funck-Brentano C. Hasdai D. Hoes A. Kirchhof P. Knuuti J. Kolh P. McDonagh T. Moulin C. Popescu B.A. Reiner Z. Sechtem U. Sirnes P.A. Tendera M. Torbicki A. Vahanian A. Windecker S. Funck-Brentano C. Sirnes P.A. Aboyans V. Ezquerra E.A. Baigent C. Brotons C. Burell G. Ceriello A. De Sutter J. Deckers J. Del Prato S. Diener H-C. Fitzsimons D. Fras Z. Hambrecht R. Jankowski P. Keil U. Kirby M. Larsen M.L. Mancia G. Manolis A.J. McMurray J. Pajak A. Parkhomenko A. Rallidis L. Rigo F. Rocha E. Ruilope L.M. van der Velde E. Vanuzzo D. Viigimaa M. Volpe M. Wiklund O. Wolpert C. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 2012 33 13 1635 1701 10.1093/eurheartj/ehs092
    [Google Scholar]
  183. Freak-Poli R. Hu J. Phyo A.Z.Z. Barker S.F. Social Isolation and Social Support Influence Health Service Utilisation and Survival after a Cardiovascular Disease Event: A Systematic Review. Int. J. Environ. Res. Public Health 2023 20 6 4853 10.3390/ijerph20064853
    [Google Scholar]
  184. Turcu A.M. Ilie A.C. Ștefăniu R. Țăranu S.M. Sandu I.A. Alexa-Stratulat T. Pîslaru A.I. Alexa I.D. The Impact of Heart Rate Variability Monitoring on Preventing Severe Cardiovascular Events. Diagnostics (Basel) 2023 13 14 2382 10.3390/diagnostics13142382
    [Google Scholar]
  185. Zeid S. Buch G. Velmeden D. Söhne J. Schulz A. Schuch A. Heart rate variability: reference values and role for clinical profile and mortality in individuals with heart failure. Clin. Res. Cardiol. 2023
    [Google Scholar]
  186. Sidorenko L. Sidorenko I. Gapelyuk A. Wessel N. Pathological Heart Rate Regulation in Apparently Healthy Individuals. Entropy (Basel) 2023 25 7 1023 10.3390/e25071023
    [Google Scholar]
  187. Yan S.P. Song X. Wei L. Gong Y.S. Hu H.Y. Li Y.Q. Performance of heart rate adjusted heart rate variability for risk stratification of sudden cardiac death. BMC Cardiovasc. Disord. 2023 23 1 144 10.1186/s12872‑023‑03184‑0
    [Google Scholar]
  188. Santosa A. Rosengren A. Ramasundarahettige C. Rangarajan S. Gulec S. Chifamba J. Lear S.A. Poirier P. Yeates K.E. Yusuf R. Orlandini A. Weida L. Sidong L. Yibing Z. Mohan V. Kaur M. Zatonska K. Ismail N. Lopez-Jaramillo P. Iqbal R. Palileo-Villanueva L.M. Yusufali A.H. AlHabib K.F. Yusuf S. Psychosocial Risk Factors and Cardiovascular Disease and Death in a Population-Based Cohort From 21 Low-, Middle-, and High-Income Countries. JAMA Netw. Open 2021 4 12 e2138920 10.1001/jamanetworkopen.2021.38920
    [Google Scholar]
  189. Burlacu A. Brinza C. Popa I.V. Covic A. Floria M. Influencing Cardiovascular Outcomes through Heart Rate Variability Modulation: A Systematic Review. Diagnostics (Basel) 2021 11 12 2198 10.3390/diagnostics11122198
    [Google Scholar]
  190. Holdgaard A. Eckhardt-Hansen C. Lassen C.F. Kjesbu I.E. Dall C.H. Michaelsen K.L. Sibilitz K.L. Prescott E. Rasmusen H.K. Cognitive-behavioural therapy reduces psychological distress in younger patients with cardiac disease: a randomized trial. Eur. Heart J. 2023 44 11 986 996 10.1093/eurheartj/ehac792
    [Google Scholar]
  191. Tao T.J. Lim T.K. Yeung E.T.F. Liu H. Shris P.B. Ma L.K.Y. Lee T.M.C. Hou W.K. Internet-based and mobile-based cognitive behavioral therapy for chronic diseases: a systematic review and meta-analysis. NPJ Digit. Med. 2023 6 1 80 10.1038/s41746‑023‑00809‑8
    [Google Scholar]
  192. Chen B. Wen J. You D. Zhang Y. Implication of cognitive-behavioral stress management on anxiety, depression, and quality of life in acute myocardial infarction patients after percutaneous coronary intervention: a multicenter, randomized, controlled study. Ir. J. Med. Sci. 2023
    [Google Scholar]
  193. Rajasree Katta M. Prasad S. Tiwari A. Abdelgawad Abouzid M.R. Mitra S. The effectiveness of cognitive-behavioral therapy for heart failure patients: a narrative review. J. Int. Med. Res. 2023 51 9 03000605231198371 10.1177/03000605231198371
    [Google Scholar]
  194. Watkins L.L. LoSavio S.T. Calhoun P. Resick P.A. Sherwood A. Coffman C.J. Kirby A.C. Beaver T.A. Dennis M.F. Beckham J.C. Effect of cognitive processing therapy on markers of cardiovascular risk in posttraumatic stress disorder patients: A randomized clinical trial. J. Psychosom. Res. 2023 170 111351 10.1016/j.jpsychores.2023.111351
    [Google Scholar]
  195. Särnholm J. Skúladóttir H. Rück C. Axelsson E. Bonnert M. Bragesjö M. Venkateshvaran A. Ólafsdóttir E. Pedersen S.S. Ljótsson B. Braunschweig F. Cognitive Behavioral Therapy Improves Quality of Life in Patients With Symptomatic Paroxysmal Atrial Fibrillation. J. Am. Coll. Cardiol. 2023 82 1 46 56 10.1016/j.jacc.2023.04.044
    [Google Scholar]
  196. Scott-Sheldon L.A.J. Gathright E.C. Donahue M.L. Balletto B. Feulner M.M. DeCosta J. Cruess D.G. Wing R.R. Carey M.P. Salmoirago-Blotcher E. Mindfulness-Based Interventions for Adults with Cardiovascular Disease: A Systematic Review and Meta-Analysis. Ann. Behav. Med. 2020 54 1 67 73 10.1093/abm/kaz020
    [Google Scholar]
  197. Zou H. Cao X. Chair S.Y. A systematic review and meta‐analysis of mindfulness‐based interventions for patients with coronary heart disease. J. Adv. Nurs. 2021 77 5 2197 2213 10.1111/jan.14738
    [Google Scholar]
  198. Loucks E.B. Britton W.B. Howe C.J. Eaton C.B. Buka S.L. Positive Associations of Dispositional Mindfulness with Cardiovascular Health: the New England Family Study. Int. J. Behav. Med. 2015 22 4 540 550 10.1007/s12529‑014‑9448‑9
    [Google Scholar]
  199. Nardi W.R. Harrison A. Saadeh F.B. Webb J. Wentz A.E. Loucks E.B. Mindfulness and cardiovascular health: Qualitative findings on mechanisms from the mindfulness-based blood pressure reduction (MB-BP) study. PLoS One 2020 15 9 e0239533 10.1371/journal.pone.0239533
    [Google Scholar]
  200. Lee S.Y. Gathright E.C. Wu W.C. Salmoirago-Blotcher E. Mindfulness-Based Interventions for Patients with Cardiovascular Disease: A Focused Review for Practicing Clinicians. Curr. Cardiol. Rep. 2023 25 4 185 191 10.1007/s11886‑023‑01846‑1
    [Google Scholar]
  201. Maslej M.M. Bolker B.M. Russell M.J. Eaton K. Durisko Z. Hollon S.D. Swanson G.M. Thomson J.A. Jr Mulsant B.H. Andrews P.W. The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis. Psychother. Psychosom. 2017 86 5 268 282 10.1159/000477940
    [Google Scholar]
  202. Potočnjak I. Degoricija V. Vukičević Baudoin D. Čulig J. Jakovljević M. Cardiovascular side effects of psychopharmacologic therapy. Int. J. Cardiol. 2016 219 367 372 10.1016/j.ijcard.2016.06.057
    [Google Scholar]
  203. Shanmugam G. Polyphenols: potent protectors against chronic diseases. Nat. Prod. Res. 2024 ••• 1 3
    [Google Scholar]
  204. Sharebiani H. Mokaram M. Mirghani M. Fazeli B. Stanek A. The Effects of Antioxidant Supplementation on the Pathologic Mechanisms of Metabolic Syndrome and Cardiovascular Disease Development. Nutrients 2024 16 11 1641 10.3390/nu16111641
    [Google Scholar]
  205. Chen Z. Zhang S.L. The role of flavonoids in the prevention and management of cardiovascular complications: a narrative review. Ann. Palliat. Med. 2021 10 7 8254 8263 10.21037/apm‑21‑1343
    [Google Scholar]
  206. Rodríguez-Landa J.F. German-Ponciano L.J. Puga-Olguín A. Olmos-Vázquez O.J. Pharmacological, Neurochemical, and Behavioral Mechanisms Underlying the Anxiolytic- and Antidepressant-like Effects of Flavonoid Chrysin. Molecules 2022 27 11 3551 10.3390/molecules27113551
    [Google Scholar]
  207. Wróbel-Biedrawa D. Grabowska K. Galanty A. Sobolewska D. Podolak I. A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders. Life (Basel) 2022 12 4 591 10.3390/life12040591
    [Google Scholar]
  208. Lopresti A.L. Potential Role of Curcumin for the Treatment of Major Depressive Disorder. CNS Drugs 2022 36 2 123 141 10.1007/s40263‑022‑00901‑9
    [Google Scholar]
  209. Fattahi A. Mazini F. Jaberghaderi N. Rajabi F. Derakhshani M. Laki M. Effectiveness of acceptance and commitment therapy upon distress, emotion regulation, and self-compassion in patients with cardiovascular disease: a randomized clinical trial. Trends Psychiatry Psychother. 2023 10.47626/2237‑6089‑2023‑0685
    [Google Scholar]
  210. Al-Kaisey A.M. Parameswaran R. Bryant C. Anderson R.D. Hawson J. Chieng D. Segan L. Voskoboinik A. Sugumar H. Wong G.R. Finch S. Joseph S.A. McLellan A. Ling L-H. Morton J. Sparks P. Sanders P. Lee G. Kistler P.M. Kalman J.M. Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress. JAMA 2023 330 10 925 933 10.1001/jama.2023.14685
    [Google Scholar]
  211. Cohen M. Daniela M. Lorber A. Patent foramen ovale closure in post-CVA/TIA patients: psychological distress, quality of life and optimism. Int. J. Clin. Pract. 2010 64 2 182 187 10.1111/j.1742‑1241.2009.02251.x
    [Google Scholar]
  212. Lelakowska M. Matusik P.T. Podolec P.S. Olszowska M. Nessler J.M. Podolec N. Przewłocki T. Komar M. Transcatheter closure of atrial septal communication: Impact on quality of life in mid-term follow-up. Adv. Clin. Exp. Med. 2019 28 8 1079 1085 10.17219/acem/102440
    [Google Scholar]
  213. Mirzada N. Ladenvall P. Hansson P.O. Eriksson P. Taft C. Dellborg M. Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample. Int. J. Cardiol. 2018 257 46 49 10.1016/j.ijcard.2018.01.120
    [Google Scholar]
  214. Luque B. Castillo-Mayén R. Cuadrado E. Gutiérrez-Domingo T. Rubio S.J. Arenas A. Delgado-Lista J. Pérez Martínez P. Tabernero C. The Role of Emotional Regulation and Affective Balance on Health Perception in Cardiovascular Disease Patients According to Sex Differences. J. Clin. Med. 2020 9 10 3165 10.3390/jcm9103165
    [Google Scholar]
  215. Heusch A. Calaminus G. Kahl J. Schmidt K. Health related quality of life after corrective surgery for congenital heart disease. Klin. Padiatr. 2014 226 5 281 286 10.1055/s‑0034‑1382019
    [Google Scholar]
  216. Udo E.O. van Hemel N.M. Zuithoff N.P.A. Nijboer H. Taks W. Doevendans P.A. Moons K.G.M. Long term quality-of-life in patients with bradycardia pacemaker implantation. Int. J. Cardiol. 2013 168 3 2159 2163 10.1016/j.ijcard.2013.01.253
    [Google Scholar]
  217. Pedersen T.A.L. Røpcke D.M. Hjortdal V.E. Functional health status late after surgical correction of aortic coarctation. Congenit. Heart Dis. 2011 6 6 566 572 10.1111/j.1747‑0803.2011.00595.x
    [Google Scholar]
  218. Tully P.J. Baumeister H. Bennetts J.S. Rice G.D. Baker R.A. Depression screening after cardiac surgery: A six month longitudinal follow up for cardiac events, hospital readmissions, quality of life and mental health. Int. J. Cardiol. 2016 206 44 50 10.1016/j.ijcard.2016.01.015
    [Google Scholar]
  219. O’Keefe E.L. O’Keefe J.H. Lavie C.J. Exercise Counteracts the Cardiotoxicity of Psychosocial Stress. Mayo Clin. Proc. 2019 94 9 1852 1864 10.1016/j.mayocp.2019.02.022
    [Google Scholar]
  220. Manolis A.S. Manolis A.A. Exercise and Arrhythmias: A Double‐Edged Sword. Pacing Clin. Electrophysiol. 2016 39 7 748 762 10.1111/pace.12879
    [Google Scholar]
  221. Schilling R. Colledge F. Ludyga S. Pühse U. Brand S. Gerber M. Does Cardiorespiratory Fitness Moderate the Association between Occupational Stress, Cardiovascular Risk, and Mental Health in Police Officers? Int. J. Environ. Res. Public Health 2019 16 13 2349 10.3390/ijerph16132349
    [Google Scholar]
  222. Kleisiaris C.F. Sfakianakis C. Papathanasiou I.V. Health care practices in ancient Greece: The Hippocratic ideal. J. Med. Ethics Hist. Med. 2014 7 6
    [Google Scholar]
  223. Crombie K.M. Adams T.G. Dunsmoor J.E. Greenwood B.N. Smits J.A. Nemeroff C.B. Cisler J.M. Aerobic exercise in the treatment of PTSD: An examination of preclinical and clinical laboratory findings, potential mechanisms, clinical implications, and future directions. J. Anxiety Disord. 2023 94 102680 10.1016/j.janxdis.2023.102680
    [Google Scholar]
  224. Blumenthal J.A. Rozanski A. Exercise as a therapeutic modality for the prevention and treatment of depression. Prog. Cardiovasc. Dis. 2023 77 50 58 10.1016/j.pcad.2023.02.008
    [Google Scholar]
  225. Hasbani N.R. Ligthart S. Brown M.R. Heath A.S. Bebo A. Ashley K.E. Boerwinkle E. Morrison A.C. Folsom A.R. Aguilar D. de Vries P.S. American Heart Association’s Life’s Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease. Circulation 2022 145 11 808 818 10.1161/CIRCULATIONAHA.121.053730
    [Google Scholar]
  226. Lloyd-Jones D.M. Allen N.B. Anderson C.A.M. Black T. Brewer L.C. Foraker R.E. Grandner M.A. Lavretsky H. Perak A.M. Sharma G. Rosamond W. Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Circulation 2022 146 5 e18 e43 10.1161/CIR.0000000000001078
    [Google Scholar]
  227. Gao B. Song S. Guo J. Associations between life’s simple 7 and incident depression among adults aged 50 years and older: A 15-year cohort study. Psychiatry Res. 2023 320 115046 10.1016/j.psychres.2022.115046
    [Google Scholar]
  228. Lim G.E.H. Tang A. Chin Y.H. Yong J.N. Tan D. Tay P. Chan Y.Y. Lim D.M.W. Yeo J.W. Chan K.E. Devi K. Ong C.E.C. Foo R.S.Y. Tan H-C. Chan M.Y. Ho R. Loh P.H. Chew N.W.S. A network meta-analysis of 12,116 individuals from randomized controlled trials in the treatment of depression after acute coronary syndrome. PLoS One 2022 17 11 e0278326 10.1371/journal.pone.0278326
    [Google Scholar]
  229. Sun J. Li Y. Zhao M. Yu X. Zhang C. Magnussen C.G. Xi B. Association of the American Heart Association’s new “Life’s Essential 8” with all-cause and cardiovascular disease-specific mortality: prospective cohort study. BMC Med. 2023 21 1 116 10.1186/s12916‑023‑02824‑8
    [Google Scholar]
  230. Manolis A.A. Manolis T.A. Melita H. Manolis A.S. Features of a Balanced Healthy Diet with Cardiovascular and Other Benefits. Curr. Vasc. Pharmacol. 2023 21 3 163 184 10.2174/1570161121666230327135916
    [Google Scholar]
/content/journals/cvp/10.2174/0115701611328094241104062903
Loading
Emotional Stress in Cardiac and Vascular Diseases
Bentham Science Publishers ; https://doi.org/10.2174/0115701611328094241104062903
/content/journals/cvp/10.2174/0115701611328094241104062903
/content/journals/cvp/10.2174/0115701611328094241104062903
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: coronary artery disease ; hypothalamic-pituitary-adrenal axis ; acute coronary syndrome ; renin-angiotensin system ; hypertension ; heart failure ; Emotional stress ; sudden cardiac death ; cardiac arrhythmias ; stroke ; sympathetic nervous system ; depression ; inflammation ; cardiovascular disease ; anxiety ; endothelial dysfunction

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test